Xanthelasma Palpebrarum
4 clinical trials · Condition
◉ Watch Xanthelasma Palpebrarum
| Record | Firm | Date |
|---|---|---|
| Topical 2% Simvastatin for Xanthelasma Palpebrarum (NCT07662785) | Klira Skin | 2026-08-01 |
| Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum (NCT06869291) | Fuzhou First General Hospital Skin Disease Prevention and Control Hospital | 2025-02-01 |
| Efficacy of 100% Trichloroacetic Acid Vs. Cryotherapy in Xanthelasma Palpebrarum (NCT06839638) | Nishtar Medical University | 2024-09-07 |
| Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors (NCT06206681) | Sun Yat-sen University | 2022-11-01 |
Track Xanthelasma Palpebrarum automatically
Every clearance here is in the API, with alerts when new ones post.